DOCSLIB.ORG

Drug Index and Glossary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Drug Index and Glossary Drug index and glossary Approt'ed name Proprieta~v name Proprw/ary name Page (UK) (USA) number Acetaminophen 233 (set Paracetamol) Alcohol 23, 28, 3I, IIS (stt Ethanol) Aloes 30 Alpha-sympathomimetics 23 Aluminium Hydroxide Alu-Cap Many preparations 70 Aludrox available Amikacin Ami kin Amikin I3S, IS2, 24I Aminoglycosides 8, IZ4, IJO, IJS, ISO Gentamicin Cidomycin Garamycin I24, I33, I3S, Garamycin ISO, 241 Genticin Kanamycin Kannasyn Kantrex 24I Kant rex Neomycin Mycifradin Mycifradin 8 Nivemycin Neobiotic Many combination Neo Tabs preparations available Streptomycin I34, I3S Tobramycin Nebcin Nebcin 24I Aminophylline Cardophylin Aminodur 242 Phyllocontin Panamin Somophyllin Aminosalicylic Acid Pamisyl 127 (Para-aminosalicylic Parasal acid) Pascorbic Rezipas Amoxycillin Amoxil Amoxil I39 (Amoxicillin) Larotid Polymox Robamox Trimox Wymox Amphetamines 23 Amphotericin Fungilin Fungizone '72 Fungizone Ampicillin Amfipen Penbritin 28, I32, 24I Penbritin Many preparations Pentrexyl available Vidopen Amylobarbitone Amytal Amytal 8s (Amobarbital) Anaesthetic Gases I8 Anaesthetics Local 7 Epidural 82 General 7 Approred name Proprietary name Proprietary name Page (UK) (USA) number Analgesics 7. 8, 29 Androgens 14, 31 Antacids 18 Antibiotics (see Antimicrobial Drugs) Anticholinesterases 9 Anticoagulants g, 10, 29 Anticonvulsants I I, 12, 29, 82, 83, 98-102 Antidepressant Drugs II, 29 Anti-emetics 18, 63--{,g. 7tr-73 Anti-epileptic Drugs II, 12,29 Antihypertensive Drugs 93 (see Hypotensive Drugs) Antimalarials 12 Antimetabolites 6 Antimicrobial Drugs 6, 8, g, 18-20, 28, 29, 123-127, 135-174, 241 Antimitotic Drugs 6, ll Antiseptics 174-177 Antithyroid Drugs 12, 29 Antitoxins Mixed Gas-Gangrene 40 Tetanus 34 Asprin Many preparations Many preparations 7. 29, 232 available available Atropine Many combination Many combination 29, 31, 184, 229 preparalions preparations Azathioprine Imuran 14 Azlocillin Securopen 241 BarbiiUrates 21, 25, 29, 30, 84 Benzalkonium Capitol Zephiran '75 Ion ax Many combination Rocca I preparations Many combination preparations Benzathine Penidural 129 Penicillin Benzodiazepines 25, 82, 83, 86 Benzylpenicillin Crystapen G Pentids 28, 125, 126, (Penicillin G) Pfizer pen 127, 130, 131, 132, 136 Bephenium Alcopar 182 Betamethasone Betnelan Celeslone 117 Betnesol Beta-sympathometics loB--114 Approved name Proprietary name Proprietary name Page (UK) (USA) number Beta-sympatholytics So, 95--97 Bromelain Ananase Ananase 238 Bromethol 8], 101 Bromides JO Bromocriprine Parlodel Parlodel Jl Bupivacaine Marcain Marcaine 224, 226 Busulphan Myleran Myleran 6 Butobarbitone Soneryl 86 (Butabarbital) Calciferol Many preparations Dee-Caps 30 Drisdol Ultra 'D' Calcium Gluconate 99 Injection Cannabis 23 Carbamazepine Tegretol Tegretol II Carbenicillin Pyopen Geopen 135, 142, 143, Pyopen 241 Carbimazole Neo-Mercazole 12, 29 Carfecillin Uticillin 135. 142 Cascara Sagrada Cas-Evac 30 Cefoxitin Mefoxin Mefoxin 144, 145 Cefuroxime Zinacef 128, IJI, 144, 145 Cephaloridine Ceporin Loridine 129, 144 Cephalosporins 125, 126, IJI, 133, 144 Cephalothin Kellin Keflin IJ2, 144 Cephazolin Kefzol Ancef 144 Kefzol Cetrimide Cetavlon 192 Many combination preparations Chloral Hydrate Noctec Aq uachloral 89 Noctec Chlorambucil Leukeran Leukeran 6 Chloramphenicol Chloromycetin 8, 29, 125, 178, Kemicetine 187, 241 Chlordiazepoxide Librium A-poxide 25, 86 Tropium Libri1abs Librium SK-Lygen Chlorhexidine Many preparations Hibiclens 192, 193 Hibitane Chlorinated Lime Milton 175 Chlormethiazole Heminevrin QI, 101 Chloroform 83 Chloroquine Aulochlor Aralen 180 Nivaquine Chlorothiazide Sal uric Chlorulan IOJ Diuril Approved name Proprietary name Proprietary name Page (UK) (USA) number Chloroxylenol Dettol 193 Chlorpromazine Largactil Promachlor 21, 30, 69, 82, Thorazine 83 Chlorpropramide Diabenese Diabenese 13 Melitase lnsulase Cholera Vaccine 32, 36 Chymotrypsin Chymoral Alpha Chymar 238 Deanase DC Avazyme Chymoral Clindamycin Dalacin C Cleocin 125, 130, 131, 1]4, 153 Clofazimine Lamprene 177 Clonidine Catapres Cat a pres 79, So Dixarit Clostridium Infections 40,41 (see Gas-Gangrene) Cloxacillin Cloxapen 241 Tegopen Copper Intra-uterine 20 devices Corticosteroids 21, I 17-119 (see Cortisone, Glucocorticoids) Cortisone Corte! an 243 Cortistab Cortisyl Co-trimazine Coptim 18, 29 Co-trimoxazole Bactrim Bactrim 18, 29, 124, 125, Septrin Septra 128, 147. 181, Septra OS 241 Crystal Violet 128, 176 (Gentian Violet) Cyanocobalamin Cytacon Berubigen 46, 6o (Vitamin B 12) Cytamen Betalin 12 Rubramin PC Many combination preparations Cyclopentolate Mydrilate 242 Danthron Several combination Dorbane 30 preparations Modane Dapsone Maloprim (also Avlosulfon 127, 177, 180, contains 181 Pyrimethamine) Debrisoquine Declinax So Dexamethasone Decadron Dalal one 118 Sodium Phosphate Dexacortisyl Decadron Oradex on Dexasone Dexone Hexadrol Dexamphetamine Dexedrine Dexampex 23 (Dex~oamphetamine) Dexedrine Approt'ed name Proprietary name Proprietary name Page (UK) (USA) number Dextropropoxyphene Depronal SA Darvon N 234 (Propoxyphene) Doloxene Dolene SK-65 Diamorphine 24, 214 (Heroin) Diazepam Atensine Valium II, 25, 30, 82, Diazemuls 83. 86, 87, Evacalm 100, 189. 192 Sedapam Solis Valium Diazoxide Eudemine Hyperstat 13, 79, So, 101 Proglycem Dichloralphenazone Well dorm Midrin 90 Dicoumarol 9 (Dicumarol) Dicyclomine (see Doxylamine) Diethylcarbamazine Banocide Hetrazan 182, 183 Digoxin Lanoxin Lanoxin 242 Dihydrocodeine DF118 236 Dihydrotachysterol AT 10 Hytakerol 16 Tachyrol Diloxanide q8 Dimenhydrinate Dramamine Dramamine 68 Dinoprost (see Prostaglandins) Dinoprostone (see Prostaglandins) Diuretics 13, 31, 83, 103-105 Doxylamine with Debendox Bendectin contains 18, 63, 64 Dicyclomine and doxylamine and Pyridoxine pyridoxine El Tor Cholera Vaccine 36 Enema Saponis 207 Enemata 207 Enteric Fever 37 Ergometrine Ergotrate 83, 189, 196, 197. 204-206 Erythromycin Erycin Bristamycin 128, 129, 135. Erythrocin E.E.S. 154 Erythromid E-Mycin llosone Erythrocin llotycin Ethril Retcin llosone llotycin Kenmycin Robimycin Wyamycin Ethambutol Myambutol Myambuto! 127, 165 Ethanol 23, 28, 31, 115 Approred name Proprietary name Proprietary name Pa~:e (UK) (USA) number Ethistewne 15 Ethyl Chloride 183 Etidocaine Duranest 224, 226 "Feospan' 55 (Trade name) 'Ferrogradumet' 'Fero-Gradumet' 55 Ferrous Fumarate Fersaday Feostat 52 Fersamal Hemocyte Gal fer Span Ferrous Gluconate Fergon Fergon 52 Ferra let Ferrous Glycine Fe-Cap 53 Sulphate Ferrocontin Kelferon Plesmet and other combination preparations Ferrous Succinate Ferromyn 53, 54 Ferromyn S Ferrous Sulphate Feospan Fcosol SI, 242 Ferro-gradumet Fero-Gradumet and other I rom in combination preparations Ferrous Sulphate with Many preparations Many preparations 53 Ascorbic Acid Flucloxacillin Floxapen 125, 135, 140 Fluoride 30 Folic Acid Many preparations Folvite II, 12, 18, 58, available 59, 124, 127, 179, 242 Frusemide Dryptal Lasix 8j, 103 (Furosemide) Frusetic Lasix Fusidic Acid Fucidin IJS Gamma Benzene Lorexane Kwell 187 Hexachloride Quell ada Gamma Globulin 32 Ganglion Blockers 28, 79 Gas-Gangrene 40,41 Antitoxin (mixed) Gentamicin Cidomycin Garamycin 29, ISO Garamycin Genticin Gentian Violet 128 (Crystal Violet) Glucocorticoids 21, I()(), 117-119 (see also Cortisone, Corticosteroids) Hashish 2J Approred name Proprietary name Proprietary name Page (UK) (USA) number Heparin Calci parine Heprinar 9 Hepsal Lipo-Hepin Minihep Panheprin Uniparin Hepatitis Serum 39.40 Heroin Not available 24, 214 (Diamorphine) Hexachlorophane Phisomed Burdeo 176 Ster-Zac Phisohex Combination preparations Hormones (see Corticosteroids, Sex Hormones) Hydralazine Apresoline Apresoline 20, 79, 81-83, Dralzine 94, 100, 101 Hydrocortisone Many preparations Many preparations 186 Hydrogen Peroxide Hyoxil 176 Hydroxy progesterone Prolution Depot. Delalutin 15 Hexanoate Relutin Hydroxycobalamin Cobalin H Codroxomin 6o, 186 Neo-Cytamen Hypertonic Saline 190 Hyoscine 229 (Scopolamine) Hypoglycaemic Drugs 13, 30 Hypotensive Drugs 13, 14, 20, 30, 93-<)7, IQ0-102 Human Normal 32, 43 lmmunoglobin ldoxuridine Dendrid Stoxil 12, 129 Herpid ldoxene Kericid Immunoglobulin 32,43 (Human Normal) lmmunosuppressives 14 Indomethacin 1m brilon lndocin II6, 243 lndocid Mobilan Influenza Vaccine Admune Fluax 33, 34 Fluvirin Fluogen lnfluvac Fluzone MFV-Ject Insulin Many preparations lletin IJ, 28, I 10 available Intra-uterine Devices Copper 7 20 (containing copper) CopP!'r T Gravigard Multiload Ortho-Gyne-T Apprured name Proprit'lary name Proprietary name Page (UK) (USA) number Iodides 12, 29 Iodophore Sol uti on 177, 192 Iron 20, 51-58 Iron Dextran Imferon Chromagen-0 56 Ironorm Dextraron-50 Feostat Imferon Iron with Folic Acid Many preparations Many preparations 54 available available Iron Sodium Edetate Sytron 53 Iron-Sorbitol Jectofer 57 Isoniazid Rimifon INH 19, 12], 166 Combination Nydrazid preparations lsoxsuprine Defencin Vasodilan 108, I II Hydrochloride Duvadilan Kanamycin Kannasyn Kanrrex 8, 29 Kantrex Laxatives JO Levamisole 183 Lidocaine (see Lignocaine) Lignocaine Lidothesin Anestacon 98, 189, 222, (Lidocaine) Xylocaine Xylocaine 225 Xylotox Lithium Camcolit Eskalith II, 29 Liskonum Lithane Litarex Lithotabs Phasal Lithonate-S Priadel Lorazepam Ativan Ativan 25 Lysergic Acid 24 Diethylamide (L.S.D.) 'Lytic Cocktail' 101 Magnesium Carbonate ]0 Magnesium Hydroxide Many preparations 18, ]0, ]I, 121 available Magnesium Sulphate 82, 83, 98, 100, 101 Magnesium Trisilicate Many preparations 18, ]0, 72 available Mannitol 8], 104, 191 Measles Vaccine Atenuvax Attenuvax 45 Mevilin-L
Load more

Recommended publications
  • PRODUCT MONOGRAPH ORCIPRENALINE Orciprenaline Sulphate Syrup House Standard 2 Mg/Ml Β2-Adrenergic Stimulant Bronchodilator AA P
    PRODUCT MONOGRAPH ORCIPRENALINE Orciprenaline Sulphate Syrup House Standard 2 mg/mL 2-Adrenergic Stimulant Bronchodilator AA PHARMA INC. DATE OF PREPARATION: 1165 Creditstone Road, Unit #1 April 10, 2014 Vaughan, Ontario L4K 4N7 Control Number: 172362 1 PRODUCT MONOGRAPH ORCIPRENALINE Orciprenaline Sulfate Syrup House Standard 2 mg/mL THERAPEUTIC CLASSIFICATION 2–Adrenergic Stimulant Bronchodilator ACTIONS AND CLINICAL PHARMACOLOGY Orciprenaline sulphate is a bronchodilating agent. The bronchospasm associated with various pulmonary diseases - chronic bronchitis, pulmonary emphysema, bronchial asthma, silicosis, tuberculosis, sarcoidosis and carcinoma of the lung, has been successfully reversed by therapy with orciprenaline sulphate. Orciprenaline sulphate has the following major characteristics: 1) Pharmacologically, the action of orciprenaline sulphate is one of beta stimulation. Receptor sites in the bronchi and bronchioles are more sensitive to the drug than those in the heart and blood vessels, so that the ratio of bronchodilating to cardiovascular effects is favourable. Consequently, it is usually possible clinically to produce good bronchodilation at dosage levels which are unlikely to cause cardiovascular side effects. 2 2) The efficacy of the bronchodilator after both oral and inhalation administration has been demonstrated by pulmonary function studies (spirometry, and by measurement of airways resistance by body plethysmography). 3) Rapid onset of action follows administration of orciprenaline sulphate inhalants, and the effect is usually noted immediately. Following oral administration, the effect is usually noted within 30 minutes. 4) The peak effect of bronchodilator activity following orciprenaline sulphate generally occurs within 60 to 90 minutes, and this activity lasts for 3 to 6 hours. 5) Orciprenaline sulphate taken orally potentiates the action of a bronchodilator inhalant administered 90 minutes later, whereas no additive effect occurs when the drugs are given in reverse order.
    [Show full text]
  • Infant Antibiotic Exposure Search EMBASE 1. Exp Antibiotic Agent/ 2
    Infant Antibiotic Exposure Search EMBASE 1. exp antibiotic agent/ 2. (Acedapsone or Alamethicin or Amdinocillin or Amdinocillin Pivoxil or Amikacin or Aminosalicylic Acid or Amoxicillin or Amoxicillin-Potassium Clavulanate Combination or Amphotericin B or Ampicillin or Anisomycin or Antimycin A or Arsphenamine or Aurodox or Azithromycin or Azlocillin or Aztreonam or Bacitracin or Bacteriocins or Bambermycins or beta-Lactams or Bongkrekic Acid or Brefeldin A or Butirosin Sulfate or Calcimycin or Candicidin or Capreomycin or Carbenicillin or Carfecillin or Cefaclor or Cefadroxil or Cefamandole or Cefatrizine or Cefazolin or Cefixime or Cefmenoxime or Cefmetazole or Cefonicid or Cefoperazone or Cefotaxime or Cefotetan or Cefotiam or Cefoxitin or Cefsulodin or Ceftazidime or Ceftizoxime or Ceftriaxone or Cefuroxime or Cephacetrile or Cephalexin or Cephaloglycin or Cephaloridine or Cephalosporins or Cephalothin or Cephamycins or Cephapirin or Cephradine or Chloramphenicol or Chlortetracycline or Ciprofloxacin or Citrinin or Clarithromycin or Clavulanic Acid or Clavulanic Acids or clindamycin or Clofazimine or Cloxacillin or Colistin or Cyclacillin or Cycloserine or Dactinomycin or Dapsone or Daptomycin or Demeclocycline or Diarylquinolines or Dibekacin or Dicloxacillin or Dihydrostreptomycin Sulfate or Diketopiperazines or Distamycins or Doxycycline or Echinomycin or Edeine or Enoxacin or Enviomycin or Erythromycin or Erythromycin Estolate or Erythromycin Ethylsuccinate or Ethambutol or Ethionamide or Filipin or Floxacillin or Fluoroquinolones
    [Show full text]
  • Us Anti-Doping Agency
    2019U.S. ANTI-DOPING AGENCY WALLET CARDEXAMPLES OF PROHIBITED AND PERMITTED SUBSTANCES AND METHODS Effective Jan. 1 – Dec. 31, 2019 CATEGORIES OF SUBSTANCES PROHIBITED AT ALL TIMES (IN AND OUT-OF-COMPETITION) • Non-Approved Substances: investigational drugs and pharmaceuticals with no approval by a governmental regulatory health authority for human therapeutic use. • Anabolic Agents: androstenediol, androstenedione, bolasterone, boldenone, clenbuterol, danazol, desoxymethyltestosterone (madol), dehydrochlormethyltestosterone (DHCMT), Prasterone (dehydroepiandrosterone, DHEA , Intrarosa) and its prohormones, drostanolone, epitestosterone, methasterone, methyl-1-testosterone, methyltestosterone (Covaryx, EEMT, Est Estrogens-methyltest DS, Methitest), nandrolone, oxandrolone, prostanozol, Selective Androgen Receptor Modulators (enobosarm, (ostarine, MK-2866), andarine, LGD-4033, RAD-140). stanozolol, testosterone and its metabolites or isomers (Androgel), THG, tibolone, trenbolone, zeranol, zilpaterol, and similar substances. • Beta-2 Agonists: All selective and non-selective beta-2 agonists, including all optical isomers, are prohibited. Most inhaled beta-2 agonists are prohibited, including arformoterol (Brovana), fenoterol, higenamine (norcoclaurine, Tinospora crispa), indacaterol (Arcapta), levalbuterol (Xopenex), metaproternol (Alupent), orciprenaline, olodaterol (Striverdi), pirbuterol (Maxair), terbutaline (Brethaire), vilanterol (Breo). The only exceptions are albuterol, formoterol, and salmeterol by a metered-dose inhaler when used
    [Show full text]
  • ADD/ADHD: Strattera • Allergy/Anti-Inflammatories
    EXAMPLES OF PERMITTED MEDICATIONS - 2015 ADD/ADHD: Strattera Allergy/Anti-Inflammatories: Corticosteroids, including Decadron, Depo-Medrol, Entocort, Solu-Medrol, Prednisone, Prednisolone, and Methylprednisolone Anesthetics: Alcaine, Articadent, Bupivacaine HCI, Chloroprocaine, Citanest Plain Dental, Itch-X, Lidocaine, Marcaine, Mepivacaine HCI, Naropin, Nesacaine, Novacain, Ophthetic, Oraqix, Paracaine, Polocaine, Pontocaine Hydrochloride, PrameGel, Prax, Proparacaine HCI, Ropivacaine, Sarna Ultra, Sensorcaine, Synera, Tetracaine, Tronothane HCI, and Xylocaine Antacids: Calci-Chew, Di-Gel, Gaviscon, Gelusil, Maalox, Mintox Plus, Mylanta, Oyst-Cal 500, Rolaids, and Tums Anti-Anxiety: Alprazolam, Atarax, Ativan, Buspar, Buspirone HCI, Chlordiazepoxide HCI, Clonazepam, Chlorazepate Dipotassium, Diastat, Diazepam, Hydroxyzine, Klonopin, Librium, Lorazepam, Niravam, Tranxene T-tab, Valium, Vistaril, and Xanax Antibiotics: Acetasol HC, Amoxil, Ampicillin, Antiben, Antibiotic-Cort, Antihist, Antituss, Avelox, Ceftazidime, Ceftin, Cefuroxime Axetil, Ceptaz, Cleocin, Cloxapen, Cortane-B Aqueous, Cortic, Cresylate, Debrox, Doryx, EarSol-HC, Fortaz, Gantrisin, Mezlin, Moxifloxacin, Neotic, Otocain, Principen, Tazicef, Tazidime, Trioxin, and Zyvox Anti-Depressants: Adapin, Anafranil, Asendin, Bolvidon, Celexa, Cymbalata, Deprilept, Effexor, Elavil, Lexapro, Luvox, Norpramin, Pamelor, Paxil, Pristiq, Prozac, Savella, Surmontil, Tofranil, Vivactil, Wellbutrin, Zoloft, and Zyban Anti-Diabetics: Actos, Amaryl, Avandia, Glipizide, Glucophage,
    [Show full text]
  • Etats Rapides
    List of European Pharmacopoeia Reference Standards Effective from 2015/12/24 Order Reference Standard Batch n° Quantity Sale Information Monograph Leaflet Storage Price Code per vial Unit Y0001756 Exemestane for system suitability 1 10 mg 1 2766 Yes +5°C ± 3°C 79 ! Y0001561 Abacavir sulfate 1 20 mg 1 2589 Yes +5°C ± 3°C 79 ! Y0001552 Abacavir for peak identification 1 10 mg 1 2589 Yes +5°C ± 3°C 79 ! Y0001551 Abacavir for system suitability 1 10 mg 1 2589 Yes +5°C ± 3°C 79 ! Y0000055 Acamprosate calcium - reference spectrum 1 n/a 1 1585 79 ! Y0000116 Acamprosate impurity A 1 50 mg 1 3-aminopropane-1-sulphonic acid 1585 Yes +5°C ± 3°C 79 ! Y0000500 Acarbose 3 100 mg 1 See leaflet ; Batch 2 is valid until 31 August 2015 2089 Yes +5°C ± 3°C 79 ! Y0000354 Acarbose for identification 1 10 mg 1 2089 Yes +5°C ± 3°C 79 ! Y0000427 Acarbose for peak identification 3 20 mg 1 Batch 2 is valid until 31 January 2015 2089 Yes +5°C ± 3°C 79 ! A0040000 Acebutolol hydrochloride 1 50 mg 1 0871 Yes +5°C ± 3°C 79 ! Y0000359 Acebutolol impurity B 2 10 mg 1 -[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy]phenyl] 0871 Yes +5°C ± 3°C 79 ! acetamide (diacetolol) Y0000127 Acebutolol impurity C 1 20 mg 1 N-(3-acetyl-4-hydroxyphenyl)butanamide 0871 Yes +5°C ± 3°C 79 ! Y0000128 Acebutolol impurity I 2 0.004 mg 1 N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl] 0871 Yes +5°C ± 3°C 79 ! butanamide Y0000056 Aceclofenac - reference spectrum 1 n/a 1 1281 79 ! Y0000085 Aceclofenac impurity F 2 15 mg 1 benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate
    [Show full text]
  • National Code Item Name 1
    NATIONAL CODE ITEM NAME 1 CARDIOVASCULAR SYSTEM 1A Positive inotropic drugs 1AA Digtalis glycoside 02-01-00001 Digoxin 62.5mcg Tablet 800,000 02-01-00002 Digitoxin 100mcg Tablet 800,000 02-01-00003 Digoxin 125 mcg Tablet 800,000 02-01-00004 Digoxin 250 mcg Tablet 15,000,000 02-01-00005 Digoxin 50mcg /ml PG Elixir 800,000 02-01-00006 Digoxin 250 mcg/ml inj (2ml) Ampoule 800,000 1AB PHOSPHODIESTERASE INHIBITORS 02-01-00007 Enoximone 5mg/1ml inj (20ml) Ampoule 800,000 1B DIURETICS 02-01-00008 Amiloride Hcl 5mg + Hydrochlorthiazide 50mg Tablet 50,000,000 02-01-00009 Bumetanide 1 mg Tablet 800,000 02-01-00010 Chlorthalidone 50mg Tablet 2,867,000 02-01-00011 Ethacrynic acid 50mg as sodium salt inj (powder for reconstitution) Vial 800,000 02-01-00012 Frusemide 20mg/2ml inj Ampoule 6,625,000 02-01-00013 Frusemide 10mg/ml,I.V.infusion inj (25ml) Ampoule 800,000 02-01-00014 Frusemide 40mg Tablet 20,000,000 02-01-00015 Frusemide 500mg Scored Tablet 800,000 02-01-00016 Frusemide 1mg/1ml Oral solution peadiatric Liquid 800,000 02-01-00017 Frusemide 4mg/ml Oral Solution 800,000 02-01-00018 Frusemide 8mg/ml oral Solution 800,000 02-01-00019 Hydrochlorothiazide 25mg Tablet 800,000 02-01-00020 Hydrochlorothiazide 50mg Tablet 950,000 02-01-00021 Indapamide 2.5mg Tablet 800,000 02-01-00022 Indapamide 1.5mg S/R Coated Tablet 800,000 02-01-00023 Spironolactone 25mg Tablet 7,902,000 02-01-00024 Spironolactone 100mg Tablet 11,451,000 02-01-00025 Xipamide 20mg Tablet 800,000 1C BETA-ADRENOCEPTER BLOCKING DRUGS 02-01-00026 Acebutolol 100mg Tablet 800,000 02-01-00027 Acebutolol 200mg Tablet 800,000 02-01-00028 Atenolol 100mg Tablet 120,000,000 02-01-00029 Atenolol 50mg Tablet or (scored tab) 20,000,000 02-01-00030 Atenolol 25mg Tablet 1,483,000 02-01-00031 Bisoprolol fumarate 5mg Scored Tablet 800,000 02-01-00032 Bisoprolol fumarate 10mg Scored Tablet 800,000 02-01-00033 Carvedilol 6.25mg Tablet 800,000 02-01-00034 Carvedilol 12.5mg Tablet 800,000 02-01-00035 Carvedilol 25mg Tablet 800,000 02-01-00036 Esmolol Hcl 10mg/ml I.V.
    [Show full text]
  • Clinical Trial of Orciprenaline in Bradyarrhythmias
    100 SINGAPORE MEDICAL JOURNAL Vol. 16, No. 2. June, 1975. CLINICAL TRIAL OF ORCIPRENALINE IN BRADYARRHYTHMIAS By Chin Hock, Lirn, Charles C. S. Toh and Oon Teik, Khoo SYNOPSIS The intravenous and oral forms of orciprenaline was used in the treatment of patients with severe sinus bradycardia, high grade atrio -ventricular block or the sick sinus syndrome. Intra- venous orciprenaline can be used to tide patients over a period of severe bradyarrhythmia, or prior to cardiac pacing. One patient developed ventricular tachycardia following an intravenous bolus of orciprenaline. Oral orciprenaline was used in 23 patients with severe bradyarrhythmia. Two patients responded poorly to it. Saventrine was given sequentially in nine patients. The merits and side effects of both drugs are discussed. INTRODUCTION efficiency of orciprenaline and to compare it with Saventrine in the treatment of complete In 1952, Nathanson and Miller introduced heart block and other forms of bradyarrhyth- isoprenaline for the treatment of heart block and mias. it still has an important role in the treatment of bradyarrhythmias. Nis Innissen and Thompson PHARMACOLOGY (1965) felt that the use of a sustained release form of isoprenaline could reduce the need for Orciprenaline (Alupent*) is a derivative of pacemakers. Intravenous isoprenaline and orci- isoprenaline but it has predominant beta -two prenaline may be used to treat patients with stimulatine effects and is commonly used as a Stokes Adams (S.A.) attacks resulting from very bronchodilator (Bogdan, 1969). However, it has slow ventricular rates in acute myocardial chronotropic and inotropic effects. It stimulates infarction, either alone or prior to cardiac the sino -atrial and atrioventricular nodes and pacing.
    [Show full text]
  • Partial Agreement in the Social and Public Health Field
    COUNCIL OF EUROPE COMMITTEE OF MINISTERS (PARTIAL AGREEMENT IN THE SOCIAL AND PUBLIC HEALTH FIELD) RESOLUTION AP (88) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (Adopted by the Committee of Ministers on 22 September 1988 at the 419th meeting of the Ministers' Deputies, and superseding Resolution AP (82) 2) AND APPENDIX I Alphabetical list of medicines adopted by the Public Health Committee (Partial Agreement) updated to 1 July 1988 APPENDIX II Pharmaco-therapeutic classification of medicines appearing in the alphabetical list in Appendix I updated to 1 July 1988 RESOLUTION AP (88) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (superseding Resolution AP (82) 2) (Adopted by the Committee of Ministers on 22 September 1988 at the 419th meeting of the Ministers' Deputies) The Representatives on the Committee of Ministers of Belgium, France, the Federal Republic of Germany, Italy, Luxembourg, the Netherlands and the United Kingdom of Great Britain and Northern Ireland, these states being parties to the Partial Agreement in the social and public health field, and the Representatives of Austria, Denmark, Ireland, Spain and Switzerland, states which have participated in the public health activities carried out within the above-mentioned Partial Agreement since 1 October 1974, 2 April 1968, 23 September 1969, 21 April 1988 and 5 May 1964, respectively, Considering that the aim of the Council of Europe is to achieve greater unity between its members and that this
    [Show full text]
  • Pharmaceuticals Appendix
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ADAPALENE 106685-40-9 ABANOQUIL 90402-40-7 ADAPROLOL 101479-70-3 ABECARNIL 111841-85-1 ADEMETIONINE 17176-17-9 ABLUKAST 96566-25-5 ADENOSINE PHOSPHATE 61-19-8 ABUNIDAZOLE 91017-58-2 ADIBENDAN 100510-33-6 ACADESINE 2627-69-2 ADICILLIN 525-94-0 ACAMPROSATE 77337-76-9 ADIMOLOL 78459-19-5 ACAPRAZINE 55485-20-6 ADINAZOLAM 37115-32-5 ACARBOSE 56180-94-0 ADIPHENINE 64-95-9 ACEBROCHOL 514-50-1 ADIPIODONE 606-17-7 ACEBURIC ACID 26976-72-7 ADITEREN 56066-19-4 ACEBUTOLOL 37517-30-9 ADITOPRIME 56066-63-8 ACECAINIDE 32795-44-1 ADOSOPINE 88124-26-9 ACECARBROMAL 77-66-7 ADOZELESIN 110314-48-2 ACECLIDINE 827-61-2 ADRAFINIL 63547-13-7 ACECLOFENAC 89796-99-6 ADRENALONE 99-45-6 ACEDAPSONE 77-46-3 AFALANINE 2901-75-9 ACEDIASULFONE SODIUM 127-60-6 AFLOQUALONE 56287-74-2 ACEDOBEN 556-08-1 AFUROLOL 65776-67-2 ACEFLURANOL 80595-73-9 AGANODINE 86696-87-9 ACEFURTIAMINE 10072-48-7 AKLOMIDE 3011-89-0 ACEFYLLINE CLOFIBROL 70788-27-1
    [Show full text]
  • Orciprenaline Sulphate (Alupent): Planned Withdrawal from the UK Market Following a Risk-Benefit Analysis
    MHRA PUBLIC ASSESSMENT REPORT Orciprenaline sulphate (Alupent): planned withdrawal from the UK market following a risk-benefit analysis November 2009 Executive summary 2 1. Introduction 3 2. Summary of data 3 2.1 Clinical pharmacology 3 2.2 Efficacy 3 2.3 Safety 4 3. Conclusions 8 4. References 9 5. Glossary 10 1 EXECUTIVE SUMMARY (Please note that this summary is intended to be accessible to all members of the public, including health professionals) Background The Medicines and Healthcare products Regulatory Agency (MHRA) is the government agency responsible for regulating the effectiveness and safety of medicines and medical devices in the UK. We continually review the safety of all medicines in the UK, and inform healthcare professionals and the public of the latest safety updates. In our Public Assessment Reports, we discuss the evidence for a safety issue with a particular drug or drug class, and changes made to the product information for the drug on the basis of this evidence, which will help safeguard public health. This MHRA Public Assessment Report discusses a review of the risks and benefits of a medicine called orciprenaline sulphate. Orciprenaline sulphate is available for oral administration as a syrup used to treat reversible airways obstructiona, which is a symptom of asthmab and chronic obstructive pulmonary diseasec. It acts on specific areas in the body called β- receptors, which relaxes the muscles used for breathing and opens the airways in the lungs. Orciprenaline sulphate was licensed in 1972 and is marketed in the UK under the brand name Alupent Syrup. As with any medicine, the use of orciprenaline sulphate may lead to adverse reactions (side-effects) in some individuals, which are described in the product information, including the patient information leaflet (see the Electronic Medicines Compendium (product information) website).
    [Show full text]
  • E3 Appendix 1 (Part 1 of 2): Search Strategy Used in MEDLINE
    This single copy is for your personal, non-commercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, contact CJHP at [email protected] Appendix 1 (part 1 of 2): Search strategy used in MEDLINE # Searches 1 exp *anti-bacterial agents/ or (antimicrobial* or antibacterial* or antibiotic* or antiinfective* or anti-microbial* or anti-bacterial* or anti-biotic* or anti- infective* or “ß-lactam*” or b-Lactam* or beta-Lactam* or ampicillin* or carbapenem* or cephalosporin* or clindamycin or erythromycin or fluconazole* or methicillin or multidrug or multi-drug or penicillin* or tetracycline* or vancomycin).kf,kw,ti. or (antimicrobial or antibacterial or antiinfective or anti-microbial or anti-bacterial or anti-infective or “ß-lactam*” or b-Lactam* or beta-Lactam* or ampicillin* or carbapenem* or cephalosporin* or c lindamycin or erythromycin or fluconazole* or methicillin or multidrug or multi-drug or penicillin* or tetracycline* or vancomycin).ab. /freq=2 2 alamethicin/ or amdinocillin/ or amdinocillin pivoxil/ or amikacin/ or amoxicillin/ or amphotericin b/ or ampicillin/ or anisomycin/ or antimycin a/ or aurodox/ or azithromycin/ or azlocillin/ or aztreonam/ or bacitracin/ or bacteriocins/ or bambermycins/ or bongkrekic acid/ or brefeldin a/ or butirosin sulfate/ or calcimycin/ or candicidin/ or capreomycin/ or carbenicillin/ or carfecillin/ or cefaclor/ or cefadroxil/ or cefamandole/ or cefatrizine/ or cefazolin/ or cefixime/ or cefmenoxime/ or cefmetazole/ or cefonicid/ or cefoperazone/
    [Show full text]
  • Product Innovation and Differentiation, Intra-Industry Trade and Growth
    l$.to- oz- Product Innovation and Differentiation, Intra-IndustrY Trade and Growth A thesis submitted in fulfilment of the requirements for the Degree of Doctor of Philosophy by Geoffrey Peak The School of Economics The UniversitY of Adelaide September 2001 Table of Contents l.Introduction 1 2. Innovation and Growth: Literature Review 5 2.1 Introduction 5 2.2 Trade in Differentiated Products 5 2.3 Transport Costs... 7 2.4Trude in Differentiated Products and an "Outside Good" ..' 7 2.5 Innovation and Growth. 9 2.5. I Innovation Without Considering Trade ...'. 0 2.5.2 Innovation and Trade............. 2.5.3 Returns to Factors 2.5.3.I Trade Between Dissimilar Countries.' 2.5.3.2 Trade Between Similar Countries.. 2.5.3.3 Conclusions on Factor Proportions ....... 2.6 Conclusions 3. Innovation, Differentiation and Growth: The Underlying Logic and Arguments ........ 19 3.1 Introduction .... T9 19 3 .2 Differentiated Goods 3.3 Innovative Goods. 2t 3.4 Innovative and Differentiated Goods 27 3.4.1 Innovative and Differentiated - The Distinction 21 3.4.2 Innovation Leads to Differentiation 32 3.4.3 Differentiation Requires Innovation 32 3.4.4Penicillin..... ..JJ 3 .4.4.1 The Development of Penicillin'.........'...'.. 34 3.4.4.2 Penicillin Substitutes and Product Variety 39 3.4.4.3 Conditions for Trade Driven by Product Differentiation ....... 46 3.4.4.4 Conclusions ......... 48 3.5 Innovation, Differentiation, and Import Demand 50 3.5. 1 Consumption Goods .. 50 52 3 .5 .2 Intermediate Goods 3.6 Model of Trade in Differentiated Goods .53 3.7 Trade and Growth 63 3.7.
    [Show full text]